Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
Clinical trial NCT03903822 · COMPLETED
Trial details
- NCT number
- NCT03903822
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-13
- Primary completion
- 2020-05-07
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.